Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dyadic International (NQ: DYAI ) 1.370 +0.050 (+3.79%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Dyadic International < Previous 1 2 3 4 5 6 Next > Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications March 26, 2024 From Dyadic International, Inc. Via GlobeNewswire Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California March 21, 2024 From Dyadic International, Inc. Via GlobeNewswire Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms March 19, 2024 Via AB Newswire Topics Supply Chain Exposures Supply Chain Dyadic International Inc. (NASDAQ: DYAI): A Value Play Gaining Investor Attention March 12, 2024 Via AB Newswire Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL January 17, 2024 Via AB Newswire Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024 March 14, 2024 From Dyadic International, Inc. Via GlobeNewswire Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP March 13, 2024 Via AB Newswire CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization March 11, 2024 From Dyadic International, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session March 11, 2024 Via Benzinga Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization March 11, 2024 From Dyadic International, Inc. Via GlobeNewswire Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA March 08, 2024 Via AB Newswire Exposures Product Safety Biotech Breakthroughs: Dyadic International (NASDAQ: DYAI) Partners with Rabian BV to Combat Rabies March 01, 2024 Via AB Newswire Topics Death Exposures Death Dyadic to Attend Industry Events in March March 01, 2024 From Dyadic International, Inc. Via GlobeNewswire Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS February 28, 2024 Via AB Newswire Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform February 28, 2024 From Dyadic International, Inc. Via GlobeNewswire Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI February 26, 2024 Via AB Newswire Dyadic International Inc. (NASDAQ: DYAI) Surges 19.2% Amid Robust Trading Volume Following Expanded Collaboration with Israeli Institutes February 21, 2024 Via AB Newswire Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions February 21, 2024 From Dyadic International, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session February 19, 2024 Via Benzinga Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS February 19, 2024 Via AB Newswire 12 Health Care Stocks Moving In Friday's After-Market Session February 16, 2024 Via Benzinga Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies February 14, 2024 Via AB Newswire Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing February 13, 2024 From Dyadic International, Inc. Via GlobeNewswire Breaking Ground in BioPharma: Spotlight Companies DYAI, INBS, SANA, IOVA, BLUE February 12, 2024 Via AB Newswire Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company February 06, 2024 From Dyadic International, Inc. Via GlobeNewswire Top 5 Active Stock Buzzers Under $10: INBS, PLUG, KOPN, DYAI, MINM February 05, 2024 Via AB Newswire Dyadic to Attend BIO CEO & Investor Conference and European Industry Events February 01, 2024 From Dyadic International, Inc. Via GlobeNewswire “Revolutionizing Biotechnology: Dyadic International (NASDAQ: DYAI) Leads with C1 Platform for Swift and Efficient Protein Production” January 11, 2024 Via AB Newswire Bull Run 2024: Biopharma Healthcare Stocks Surge, Gaining Momentum: DYAI, ABVC, FWBI, VTAK, NEXI January 05, 2024 Via AB Newswire “Dyadic International Inc. (NASDAQ: DYAI): Zacks Small-Cap Research Indicates Valuation at $9.00 per Share” January 05, 2024 Via AB Newswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.